This is a preview of subscription content, log in via an institution to check access.
References
National Institute for Health and Care Excellence. NICE gives green light to treatment for macular oedema in final guidance. Media Release : 25 Feb 2014. Available from: URL: http://www.nice.org.uk.
National Institute for Health and Care Excellence. NICE recommends NHS funding for new cancer treatment. Media Release : 26 Feb 2014. Available from: URL: http://www.nice.org.uk.
The National Institute for Health and Care Excellence. NICE proposes to recommend a new treatment for some people with advanced kidney cancer. Media Release : 3 Mar 2014. Available from: URL: http://www.nice.org.uk.
The National Institute for Health and Care Excellence. High cost of treatment for rare blood disorder needs to be clarified, says NICE in draft guidance. Media Release : 3 Mar 2014. Available from: URL: http://www.nice.org.uk.
Additional information
* see PharmacoEconomics & Outcomes News 675 p10; 801085659
Rights and permissions
About this article
Cite this article
NICE recommends aflibercept for macular oedema . . .. PharmacoEcon Outcomes News 698, 11 (2014). https://doi.org/10.1007/s40274-014-1117-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1117-3